Advertisement
Screener

Quest Diagnostics Inc (DGX) Excess Tax Benefit from Share-based Compensation, Financing Activities

2.8 / 5 stars · 68/120 Roast Me

Quest Diagnostics Inc Excess Tax Benefit from Share-based Compensation, Financing Activities

Quest Diagnostics Inc (DGX) reported Excess Tax Benefit from Share-based Compensation, Financing Activities of $2.00 million for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-04-27.

Discontinued › Notes › Compensation Related Costs

us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities · last filed 2016-04-27

  • Quest Diagnostics Inc excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-03-31 was $2.00M, a 0.00% change year-over-year.
  • Quest Diagnostics Inc excess tax benefit from share-based compensation, financing activities for the quarter ending 2015-12-31 was $1.00M.
  • Quest Diagnostics Inc excess tax benefit from share-based compensation, financing activities for the quarter ending 2015-09-30 was $1.00M.
  • Quest Diagnostics Inc excess tax benefit from share-based compensation, financing activities for the quarter ending 2015-06-30 was $1.00M.
  • Quest Diagnostics Inc excess tax benefit from share-based compensation, financing activities for fiscal 2015 was $5.00M.
  • Quest Diagnostics Inc excess tax benefit from share-based compensation, financing activities for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
  • Quest Diagnostics Inc excess tax benefit from share-based compensation, financing activities for fiscal 2013 was $4.00M, a 0.00% change from fiscal 2012.
  • Quest Diagnostics Inc excess tax benefit from share-based compensation, financing activities for fiscal 2012 was $4.00M, a 0.00% change from fiscal 2011.
Period endExcess Tax Benefit from Share-based Compensation, Financing Activities 3 monthExcess Tax Benefit from Share-based Compensation, Financing Activities 3 month as first filedExcess Tax Benefit from Share-based Compensation, Financing Activities 6 monthExcess Tax Benefit from Share-based Compensation, Financing Activities 6 month as first filedExcess Tax Benefit from Share-based Compensation, Financing Activities 9 monthExcess Tax Benefit from Share-based Compensation, Financing Activities 9 month as first filedExcess Tax Benefit from Share-based Compensation, Financing Activities 12 monthExcess Tax Benefit from Share-based Compensation, Financing Activities 12 month as first filed
2016-03-31$2.00M
10-Q · filed 2016-04-27
$3.00M
derived: sum of 2 quarters · filed 2016-04-27
$4.00M
derived: sum of 3 quarters · filed 2016-04-27
$5.00M
derived: sum of 4 quarters · filed 2016-04-27
2015-12-31$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26
$2.00M
derived: sum of 2 quarters · filed 2016-02-26
$3.00M
derived: sum of 3 quarters · filed 2016-02-26
$5.00M
10-K · filed 2016-02-26
2015-09-30$1.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29
$2.00M
derived: sum of 2 quarters · filed 2015-10-29
$4.00M
10-Q · filed 2015-10-29
$4.00M
derived: sum of 4 quarters · filed 2016-04-27
2015-06-30$1.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30
$3.00M
10-Q · filed 2015-07-30
$3.00M
derived: sum of 3 quarters · filed 2016-04-27
$3.00M
derived: sum of 4 quarters · filed 2016-04-27
2015-03-31$2.00M
10-Q · filed 2016-04-27
$2.00M
derived: sum of 2 quarters · filed 2016-04-27
$2.00M
derived: sum of 3 quarters · filed 2016-04-27
$2.00M
derived: sum of 4 quarters · filed 2016-04-27
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26
$0.00
derived: sum of 2 quarters · filed 2016-02-26
$0.00
derived: sum of 3 quarters · filed 2016-02-26
$0.00
10-K · filed 2016-02-26
2014-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29
$0.00
derived: sum of 2 quarters · filed 2015-10-29
$0.00
10-Q · filed 2015-10-29
$1.00M
derived: sum of 4 quarters · filed 2016-02-26
2014-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30
$0.00
10-Q · filed 2015-07-30
$1.00M
derived: sum of 3 quarters · filed 2016-02-26
$1.00M
derived: sum of 4 quarters · filed 2016-02-26
2014-03-31$0.00
10-Q · filed 2015-04-30
$1.00M
derived: sum of 2 quarters · filed 2016-02-26
$1.00M
derived: sum of 3 quarters · filed 2016-02-26
$3.00M
derived: sum of 4 quarters · filed 2016-02-26
2013-12-31$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26
$1.00M
derived: sum of 2 quarters · filed 2016-02-26
$3.00M
derived: sum of 3 quarters · filed 2016-02-26
$4.00M
10-K · filed 2016-02-26
2013-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30
$2.00M
derived: sum of 2 quarters · filed 2014-10-30
$3.00M
10-Q · filed 2014-10-30
$3.57M
10-Q · filed 2013-10-24
$3.19M
derived: sum of 4 quarters · filed 2015-02-24
2013-06-30$2.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31
$3.00M
10-Q · filed 2014-07-31
$2.74M
10-Q · filed 2013-07-25
$3.19M
derived: sum of 3 quarters · filed 2015-02-24
$3.07M
derived: sum of 4 quarters · filed 2015-02-24
2013-03-31$1.00M
10-Q · filed 2014-05-01
$861.00K
10-Q · filed 2013-04-24
$1.19M
derived: sum of 2 quarters · filed 2015-02-24
$1.07M
derived: sum of 3 quarters · filed 2015-02-24
$1.70M
derived: sum of 4 quarters · filed 2015-02-24
2012-12-31$190.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24
$71.00K
derived: sum of 2 quarters · filed 2015-02-24
$702.00K
derived: sum of 3 quarters · filed 2015-02-24
$4.00M
10-K · filed 2015-02-24
$3.96M
10-K · filed 2013-02-27
2012-09-30-$119.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-24
$512.00K
derived: sum of 2 quarters · filed 2013-10-24
$3.81M
10-Q · filed 2013-10-24
$3.23M
derived: sum of 4 quarters · filed 2014-02-18
2012-06-30$631.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25
$3.93M
10-Q · filed 2013-07-25
$3.35M
derived: sum of 3 quarters · filed 2014-02-18
$3.14M
derived: sum of 4 quarters · filed 2014-02-18
2012-03-31$3.30M
10-Q · filed 2013-04-24
$2.72M
derived: sum of 2 quarters · filed 2014-02-18
$2.51M
derived: sum of 3 quarters · filed 2014-02-18
$2.62M
derived: sum of 4 quarters · filed 2014-02-18
2011-12-31-$575.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18
-$786.00K
derived: sum of 2 quarters · filed 2014-02-18
-$680.00K
derived: sum of 3 quarters · filed 2014-02-18
$4.00M
10-K · filed 2014-02-18
$4.47M
10-K · filed 2012-02-16
2011-09-30-$211.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24
-$105.00K
derived: sum of 2 quarters · filed 2012-10-24
$4.58M
10-Q · filed 2012-10-24
$5.43M
derived: sum of 4 quarters · filed 2013-02-27
2011-06-30$106.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26
$4.79M
10-Q · filed 2012-07-26
$5.65M
derived: sum of 3 quarters · filed 2013-02-27
$5.67M
derived: sum of 4 quarters · filed 2013-02-27
2011-03-31$4.68M
10-Q · filed 2012-04-27
$5.54M
derived: sum of 2 quarters · filed 2013-02-27
$5.56M
derived: sum of 3 quarters · filed 2013-02-27
$6.04M
derived: sum of 4 quarters · filed 2013-02-27
2010-12-31$860.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27
$880.00K
derived: sum of 2 quarters · filed 2013-02-27
$1.36M
derived: sum of 3 quarters · filed 2013-02-27
$884.00K
10-K · filed 2013-02-27
2010-09-30$20.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03
$497.00K
derived: sum of 2 quarters · filed 2011-11-03
$24.00K
10-Q · filed 2011-11-03
$2.37M
derived: sum of 4 quarters · filed 2012-02-16
2010-06-30$477.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-27
$4.00K
10-Q · filed 2011-07-27
$2.35M
derived: sum of 3 quarters · filed 2012-02-16
$3.75M
derived: sum of 4 quarters · filed 2012-02-16
2010-03-31-$473.00K
10-Q · filed 2011-05-10
$1.88M
derived: sum of 2 quarters · filed 2012-02-16
$3.28M
derived: sum of 3 quarters · filed 2012-02-16
$4.00M
derived: sum of 4 quarters · filed 2012-02-16
2009-12-31$2.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-16
$3.75M
derived: sum of 2 quarters · filed 2012-02-16
$4.48M
derived: sum of 3 quarters · filed 2012-02-16
$5.54M
10-K · filed 2012-02-16
2009-09-30$1.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-26
$2.13M
derived: sum of 2 quarters · filed 2010-10-26
$3.19M
10-Q · filed 2010-10-26
$3.53M
derived: sum of 4 quarters · filed 2011-02-16
2009-06-30$728.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2010-07-27
$1.79M
10-Q · filed 2010-07-27
$2.13M
derived: sum of 3 quarters · filed 2011-02-16
$2.99M
derived: sum of 4 quarters · filed 2011-02-16
2009-03-31$1.06M
10-Q · filed 2010-04-26
$1.40M
derived: sum of 2 quarters · filed 2011-02-16
$2.26M
derived: sum of 3 quarters · filed 2011-02-16
2008-12-31$336.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-16
$1.20M
derived: sum of 2 quarters · filed 2011-02-16
$2.42M
10-K · filed 2011-02-16
2008-09-30$861.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-27
$2.08M
10-Q · filed 2009-10-27
2008-06-30$1.22M
10-Q · filed 2009-07-28
2007-12-31$13.98M
10-K · filed 2010-02-17

Similar stocks

Stock NameCountryMarket CapPE Ratio
LABCORP HOLDINGS INC. (LH)United States$25.060B22.60
Guardant Health, Inc. (GH)United States$23.675B-12.65
Caris Life Sciences, Inc. (CAI)United States$9.119B47.87
RadNet, Inc. (RDNT)United States$5.611B-229.65
GRAIL, Inc. (GRAL)United States$5.591B-7.78
VERACYTE, INC. (VCYT)United States$3.904B41.21
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30